Robert Redd

20PUBLICATIONS

94CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAllergyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 23, 2026

SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL.

|Mar 26, 2026

A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformation.

Jennifer L Crombie, Christine E Ryan, Yue Ren

|Mar 03, 2026

Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma.

Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault

|Oct 31, 2025

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Apr 03, 2025

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

James T Yoon, Yinglu Zhou, Mariia Mikhaleva

|Feb 10, 2025

Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma.

Matthew J Frigault, Ning Yao, Trisha R Berger

Pageof 4

Frequent Collaborators

Jennifer R Brown

Ann S LaCasce

Alex Herrera

Austin I Kim

Erin M Parry

Matthew S Davids

Svitlana Tyekucheva

Jeremy S Abramson

David C Fisher

P Connor Johnson

Frequent Collaborators

Jennifer R Brown

Ann S LaCasce

Alex Herrera

Austin I Kim